CLINICAL DATA MANAGEMENT FEATURED ARTICLES
CLINICAL DATA MANAGEMENT WHITE PAPER & ARTICLES
-
Multi-vendor trial models often limit visibility and coordination. Discover how centralized operations can streamline workflows, control costs, and improve stakeholder experiences.
-
Outdated trial payment processes create costly delays. Explore strategies for centralized financial management, participant reimbursement, and improved study execution.
-
Workflow automation is only part of the solution. Integrating payments, travel, and forecasting with clinical operations supports more efficient trial execution.
-
Outdated payment workflows create delays, financial blind spots, and administrative strain in clinical trials. Evaluating integrated, real-time solutions helps reduce burden, improve visibility, and support more efficient, scalable trial execution.
-
Clinical trials are often slowed by disconnected systems. Centralizing payments, logistics, and data helps streamline operations and retain patients.
CLINICAL DATA MANAGEMENT APPLICATIONS & STUDIES
-
How A Leading Chinese Biopharmaceutical Company Modernized Clinical Operations7/15/2026
A growing biopharma pipeline needed better document oversight. Learn how automation and centralized tracking improved compliance and trial visibility.
-
Maintain Compliance Through Divestiture Without Disrupting Operations6/25/2026
Facing a divestiture? Learn how to protect historical quality records and stay audit-ready throughout the transition.
-
Optimizing Wearable Adherence In A Phase 3 Oncology Trial5/15/2026
Long-term wearable monitoring only works if patients keep wearing the device, and in oncology trials, that’s easier said than done.
-
How A Complex Personalized Medicine Trial Migrated RTSM Software Without Disruption3/26/2026
Discover how a clinical-stage biotech automated its supply chain to protect patient enrollment and eliminate manual errors in a complex, multi-national genetic medicine trial.
-
How A Rare Disease Biotech Replaced Manual Processes With RTSM Software3/26/2026
Discover how a clinical-stage biotech automated its supply chain to protect patient enrollment and eliminate manual errors in a complex, multi-national genetic medicine trial.
SOLUTIONS
- Suvoda Scheduling
- Medidata CTMS Leads The Industry
- RTSM That's Ready For The Trials Ahead
- Modernize Clinical Research With Continuous Digital Data
- Improving The Patient Experience With Total Consent
- Powering Smarter Treatments And Healthier People
- Comprehensive Global Medical Information Services
- Fast, Flexible Participant Payments In Clinical Trials
- Your Medical Imaging Workflow Solution
- Why Customers Are Switching To Medidata CTMS And eTMF
NEWS
-
Brown Astronomers Create New Technique To Eliminate Signals Disrupting Sensitive Radio Telescopes2/12/2025
Astronomers sifting through data from the Murchison Widefield Array, a radio telescope in Western Australia, found themselves confronting an unexpected mystery.
-
U.S. Department Of Energy Announces $6.9M In Projects To Support Effective Community Waste-To-Energy Strategies For Local Transportation Needs1/7/2025
The U.S. Department of Energy's (DOE) Bioenergy Technologies Office (BETO) and Vehicle Technologies Office (VTO) announced $6.9M in funding for nine projects to support local waste-to-energy management solutions for transportation energy needs.
-
Masdar And Iberdrola Announce €5.2B UK Offshore Wind Deal And Full Energization Of 476MW German Offshore Wind Farm7/10/2025
Masdar, a global clean energy leader, and Iberdrola, one of the world’s largest energy companies, have reached two major milestones with a €5.2B co-investment in the UK’s East Anglia THREE offshore wind farm – the largest offshore wind transaction of the decade – and the full energization of their 476MW Baltic Eagle project in Germany.
-
Be Part of Photonics Future: CIOE 2025 Visitor Registration Live Now!4/9/2025
The 26th China International Optoelectronic Exposition (CIOE 2025) is set to take place from September 10–12, 2025, at the Shenzhen World Exhibition & Convention Center, spanning 240,000 square meters of exhibition space.
-
Quantum Biopharma Announces Signing Of An Agreement With A Global Pharmaceutical Contract Research Organization To Prepare An IND (Investigational New Drug) Application Package For Lucid-21-302 (Lucid-MS), A First-In-Class Treatment For Multiple Sclerosis5/20/2025
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that it has signed an agreement with a global pharmaceutical contract research organization to prepare an IND (Investigational New Drug) application package for Lucid-21-302 (Lucid-MS) with the US FDA.